A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells 1

Aberrant activation of the Wingless-type (Wnt)/Bcatenin signaling pathway is associated with a variety of human cancers. Little is known regarding the role that Wnt ligands play in human carcinogenesis. To test whether a Wnt-1 signal is a survival factor in human cancer cells and thus may serve as a potential cancer therapeutic target, we investigated the effect of inhibition of Wnt-1 signaling in a variety of human cancer cell lines, including non small cell lung cancer, breast cancer, mesothelioma, and sarcoma. Both monoclonal antibody and RNA interference (RNAi) were used to inhibit Wnt-1 signaling. We found that incubation of a monoclonal anti–Wnt-1 antibody induced apoptosis and caused downstream protein changes in cancer cells overexpressing Wnt-1. In contrast, apoptosis was not detected in cells lacking or having minimal Wnt-1 expression after the antibody incubation. RNAi targeting of Wnt-1 in cancer cells overexpressing Wnt-1 demonstrated similar downstream protein changes and induction of apoptosis. The antibody also suppressed tumor growth in vivo. Our results indicate that both monoclonal anti–Wnt-1 antibody and Wnt-1 siRNA inhibit Wnt-1 signaling and can induce apoptosis in human cancer cells. These findings hold promise as a novel therapeutic strategy for cancer. Neoplasia (2004) 6, 7–14

[1]  Biao He,et al.  Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression , 2003, Oncogene.

[2]  K. Uematsu,et al.  Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. , 2003, Cancer research.

[3]  R. Jope,et al.  Central Role of Glycogen Synthase Kinase-3β in Endoplasmic Reticulum Stress-induced Caspase-3 Activation* , 2002, The Journal of Biological Chemistry.

[4]  Wendy S. Wright,et al.  Wnt Signaling Protects 3T3-L1 Preadipocytes from Apoptosis through Induction of Insulin-like Growth Factors* , 2002, The Journal of Biological Chemistry.

[5]  K. Uematsu,et al.  Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides. , 2002, Molecular cancer therapeutics.

[6]  M. Daemen,et al.  The wnt-frizzled cascade in cardiovascular disease. , 2002, Cardiovascular research.

[7]  G. Evan,et al.  Wnt signaling promotes oncogenic transformation by inhibiting c-Myc–induced apoptosis , 2002, The Journal of cell biology.

[8]  S. Wong,et al.  Expression of frizzled‐related protein and Wnt‐signalling molecules in invasive human breast tumours , 2002, The Journal of pathology.

[9]  T. Tuschl,et al.  Analysis of gene function in somatic mammalian cells using small interfering RNAs. , 2002, Methods.

[10]  Anthony MC Brown,et al.  Wnt signaling in breast cancer: have we come full circle? , 2001, Breast Cancer Research.

[11]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[12]  J C Reed,et al.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. , 2001, Molecular cell.

[13]  S. Galandiuk,et al.  Wingless‐type frizzled protein receptor signaling and its putative role in human colon cancer , 2001, Molecular carcinogenesis.

[14]  Marty W. Mayo,et al.  WNT-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor–Mediated Transcription , 2001, The Journal of cell biology.

[15]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[16]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[17]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[18]  Marty W. Mayo,et al.  NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.

[19]  J Mao,et al.  Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt‐mediated regulation of LEF‐1 , 1999, The EMBO journal.

[20]  Hideki Yamamoto,et al.  Phosphorylation of Axin, a Wnt Signal Negative Regulator, by Glycogen Synthase Kinase-3β Regulates Its Stability* , 1999, The Journal of Biological Chemistry.

[21]  S. Orsulic,et al.  E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. , 1999, Journal of cell science.

[22]  J. Loureiro,et al.  The Wnts , 1999, Current Biology.

[23]  M. Katoh.  Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by beta-estradiol in MCF-7 cells. , 2003, International journal of oncology.

[24]  J. Rubin,et al.  Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas , 2002, Oncogene.

[25]  B. Geiger,et al.  Down-regulation of beta-catenin by activated p53. , 2001, Molecular and cellular biology.

[26]  R. Benarous,et al.  The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. , 1999, Current biology : CB.